Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil in distearyldimethylammonium chloride vesicles significantly promotes hair growth, while minoxidil in microparticles or poloxamer solutions doesn't.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

The new delivery system makes retinol and niacinamide more stable and effective for anti-aging and skin-brightening.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Low-dose oral minoxidil effectively promotes hair growth with minimal side effects.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Magnesium microneedle patches can safely improve under-eye wrinkles when used every other night for 12 weeks.

Researchers developed a simple and accurate method to measure Minoxidil in tablets using UV light.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

VDAC2 promotes cell death in cashmere goat hair follicles through the P53 pathway.

Cholesterol- and phospholipid-free niosomes improve deep skin drug delivery.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Desmopressin-loaded liposomes can effectively deliver drugs through the skin, improving bioavailability and patient compliance.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Cornifin-alpha/SPRR1 is increased in certain skin conditions and by specific treatments.

Microneedles are becoming essential tools in medicine for sensing, drug delivery, and communication.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Low-dose oral minoxidil helps improve hairline and eyebrow coverage in frontal fibrosing alopecia.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Substance P helps restore skin thickness and cell renewal when sensory nerves are reduced.

Familial dyskeratotic comedones are a rare, benign skin disorder that is hard to treat.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

Dirty dots are a common scalp finding in elderly women and can be washed away with shampoo.

Low-dose oral minoxidil improves hair loss and quality of life for women, despite mild unwanted hair growth.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.